Using Dox-resistant MCF-7 breast cancer cells developed by incremental increases in Dox concentrations, we observed in the current study that H19 expression was greatly upregulated in Dox-resistant cells as well as in parental MCF-7 cells treated with anthracyclines (Figure 1). The gene discussed is H19; the disease is breast cancer.